Drugs in MeSH Category Cytochrome P-450 CYP2C19 Inducers
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Pharms Teva | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 206736-001 | Jan 19, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | RIFAMPIN | rifampin | CAPSULE;ORAL | 065028-001 | Mar 14, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | RIFAMPIN | rifampin | CAPSULE;ORAL | 064150-002 | Jan 2, 1998 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sanofi Aventis Us | RIFADIN | rifampin | INJECTABLE;INJECTION | 050627-001 | May 25, 1989 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Avet Lifesciences | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 204101-001 | Aug 18, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 091181-001 | Aug 21, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Epic Pharma Llc | RIFAMPIN | rifampin | CAPSULE;ORAL | 064150-001 | May 28, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |